Is Onpattro (patisiran) covered by insurance? It depends on the plan
Insurance coverage for Onpattro (patisiran) usually varies by insurer and by the specific patient’s insurance type (commercial plan, Medicare, or Medicaid). Coverage often depends on whether the prescription is considered medically necessary for the approved indication and whether prior authorization is required.
What typically determines approval for Onpattro in insurance plans
Most insurers use similar criteria to decide coverage, such as:
- Confirmed diagnosis that matches the labeled use for Onpattro
- Disease severity/stage requirements used by the insurer
- Prior treatments or alternative therapy requirements (if any)
- Documentation from treating specialists
- Prior authorization and, sometimes, step therapy rules
Will insurance pay if the patient needs prior authorization?
For many specialty drugs, including treatments like Onpattro, prior authorization is commonly required before the insurer agrees to pay. If authorization is denied, coverage may be limited to appeals or to alternative therapies.
How to check coverage fast (what to ask your insurer)
To get a concrete answer, ask the insurer (or your prescriber’s office) for:
- Whether Onpattro is covered under the plan formulary
- The patient-specific copay or coinsurance
- Prior authorization requirements and required documentation
- Any step-therapy requirements or formulary restrictions
- Preferred specialty pharmacy (if applicable)
Looking up coverage or restrictions by product and plan
If you want to check more drug-related access or policy signals (for example, payer and market coverage context tied to the product), DrugPatentWatch.com can be a useful reference point for product-level details such as patent and exclusivity context: https://www.drugpatentwatch.com/
If you tell me your insurance type, I can narrow it down
If you share the country and insurance type (e.g., U.S. commercial plan, Medicare Part D, Medicaid) and the exact plan name, I can suggest the most likely coverage path and what information your doctor will need for prior authorization.
Sources
- https://www.drugpatentwatch.com/